Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Virchows Archiv

• Publication date

  2004-01-28

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00428-003-0947-3PMID 14747944
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Chromosome aberrations in solid tumors

  2003influential reference
• Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers

  2003influential reference
• Abnormalities of E‐ and P‐cadherin and catenin (β‐, γ‐catenin, and p120ctn) expression in endometrial cancer and endometrial atypical hyperplasia

  2003cited by this paper
• Pathology and Genetics of Tumours of the Breast and Female Genital Organs

  2003cited by this paper
• Chromosomal imbalances in the colorectal carcinomas with microsatellite instability.

  2003cited by this paper
• Microarray analysis reveals distinct gene expression profiles among different histologic types of endometrial cancer.

  2003cited by this paper
• Differential gene expression profile in endometrioid and nonendometrioid endometrial carcinoma: STK15 is frequently overexpressed and amplified in nonendometrioid carcinomas.

  2003cited by this paper
• Frequent hypermethylation of MLH1 promoter in normal endometrium of patients with endometrial cancers

  2003cited by this paper
• Genomics and proteomics in cancer.

  2003cited by this paper
• Hypermethylation in promoter region of E‐cadherin gene is associated with tumor dedifferention and myometrial invasion in endometrial carcinoma

  2003cited by this paper
• Abnormalities of E- and P-cadherin and catenin (beta-, gamma-catenin, and p120ctn) expression in endometrial cancer and endometrial atypical hyperplasia.

  2003cited by this paper
• Loss of hMSH2 and hMSH6 expression is frequent in sporadic endometrial carcinomas with microsatellite instability: a population-based study.

  2002influential reference
• Distinct sets of gene alterations in endometrial carcinoma implicate alternate modes of tumorigenesis

  2002cited by this paper
• Clonal Analysis and Mutations in the PTEN and the K-ras Genes in Endometrial Hyperplasia

  2002cited by this paper
• E‐Cadherin Expression in Endometrioid, Papillary Serous, and Clear Cell Carcinoma of the Endometrium

  2002cited by this paper
• β-Catenin and E-Cadherin Expression Patterns in High-Grade Endometrial Carcinoma Are Associated with Histological Subtype

  2002cited by this paper
• Loss of heterozygosity of the retinoblastoma gene is correlated with the altered pRb expression in human endometrial cancer

  2002cited by this paper
• Distinct PTEN mutational spectra in hereditary non-polyposis colon cancer syndrome-related endometrial carcinomas compared to sporadic microsatellite unstable tumors.

  2002cited by this paper
• PTEN methylation is associated with advanced stage and microsatellite instability in endometrial carcinoma

  2001cited by this paper
• Pten, a protean tumor suppressor.

  2001cited by this paper
• Molecular pathology of endometrial hyperplasia and carcinoma.

  2001cited by this paper
• Favorable Survival Associated With Microsatellite Instability in Endometrioid Endometrial Cancers

  2001cited by this paper
• Cancer risk in young women at risk of hereditary nonpolyposis colorectal cancer: implications for gynecologic surveillance.

  2001cited by this paper
• Comparative immunohistochemical study of endometrioid and serous papillary carcinoma of endometrium.

  2001cited by this paper
• K-ras exon 2 point mutations in human endometrial cancer.

  2001cited by this paper
• β-Catenin mutations and aberrant nuclear expression during endometrial tumorigenesis

  2001cited by this paper
• MLH1 and MSH2 protein expression as a pre‐screening marker in hereditary and non‐hereditary endometrial hyperplasia and cancer

  2001cited by this paper
• Lack of MSH2 and MSH6 characterizes endometrial but not colon carcinomas in hereditary nonpolyposis colorectal cancer.

  2001cited by this paper
• Beta- and gamma-catenin expression in endometrial carcinoma. Relationship with clinicopathological features and microsatellite instability.

  2001cited by this paper
• Genetic imbalances in precursor lesions of endometrial cancer detected by comparative genomic hybridization.

  2000cited by this paper
• Genetic aberrations detected by comparative genomic hybridization predict outcome in patients with endometrioid carcinoma

  2000cited by this paper
• Anticorresponding mutations of the KRAS and PTEN genes in human endometrial cancer.

  2000cited by this paper
• Loss of nuclear p16 protein expression is not associated with promoter methylation but defines a subgroup of aggressive endometrial carcinomas with poor prognosis.

  2000influential reference
• Prediction of a mismatch repair gene defect by microsatellite instability and immunohistochemical analysis in endometrial tumours from HNPCC patients

  2000cited by this paper
• Frequency and prognostic impact of microsatellite instability in a large population-based study of endometrial carcinomas.

  2000cited by this paper
• The frequency of p53, k‐ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma

  2000influential reference
• Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers.

  2000influential reference
• Minimal uterine serous carcinoma: diagnosis and clinicopathologic correlation.

  2000cited by this paper
• Methylation of hMLH1 in a population-based series of endometrial carcinomas.

  2000cited by this paper
• The role of p16-cyclin D/CDK-pRb pathway in the tumorigenesis of endometrioid-type endometrial carcinoma

  2000cited by this paper
• Endometrial intraepithelial carcinoma with associated peritoneal carcinomatosis.

  2000cited by this paper
• Endometrial precancer diagnosis by histopathology, clonal analysis, and computerized morphometry

  2000cited by this paper
• Altered expression of hMLH1 and hMSH2 protein in endometrial carcinomas with microsatellite instability.

  2000influential reference
• The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.

  2000cited by this paper
• Microsatellite instability and hMLH1/hMSH2 expression in young endometrial carcinoma patients: Associations with family history and histopathology

  2000cited by this paper
• Alteration of p16 and p15 genes in human uterine tumours

  1999cited by this paper
• P16/MTS1 and pRB expression in endometrial carcinomas

  1999cited by this paper
• Fluorescence in situ hybridization analysis of HER-2/neu, c-myc, and p53 in endometrial cancer.

  1999cited by this paper
• Risk of endometrial cancer following estrogen replacement with and without progestins.

  1999cited by this paper
• Mutations of the β‐Catenin Gene in Endometrial Carcinomas

  1999cited by this paper
• Cancer risk in mutation carriers of DNA‐mismatch‐repair genes

  1999cited by this paper
• HER-2/neu amplification and overexpression in endometrial carcinoma.

  1999cited by this paper
• Causes and consequences of microsatellite instability in endometrial carcinoma.

  1999cited by this paper
• p53 expression as a prognostic indicator of 5-year survival in endometrial cancer.

  1999cited by this paper
• hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis.

  1999cited by this paper
• MLH1 promoter methylation and gene silencing is the primary cause of microsatellite instability in sporadic endometrial cancers.

  1999cited by this paper
• Clinical findings with implications for genetic testing in families with clustering of colorectal cancer.

  1998influential reference
• PTEN mutations and microsatellite instability in complex atypical hyperplasia, a precursor lesion to uterine endometrioid carcinoma.

  1998cited by this paper
• BAX somatic frameshift mutations in endometrioid adenocarcinomas of the endometrium: evidence for a tumor progression role in endometrial carcinomas with microsatellite instability.

  1998cited by this paper
• Comparison of estrogen and progesterone receptor, Ki-67, and p53 immunoreactivity in uterine endometrioid carcinoma and endometrioid carcinoma with squamous, mucinous, secretory, and ciliated cell differentiation.

  1998cited by this paper
• PTEN mutation in endometrial cancers is associated with favorable clinical and pathologic characteristics.

  1998cited by this paper
• A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.

  1998cited by this paper
• Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression.

  1998influential reference
• Microsatellite instability in endometrial carcinomas: clinicopathologic correlations in a series of 42 cases.

  1998influential reference
• Direct sequencing of the p53 gene shows absence of mutations in endometrioid endometrial adenocarcinomas expressing p53 protein

  1998cited by this paper
• MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas

  1998cited by this paper
• Correlation of proliferation indices, apoptosis, and related oncogene expression (bcl-2 and c-erbB-2) and p53 in proliferative, hyperplastic, and malignant endometrium.

  1998cited by this paper
• DCC genetic alterations and expression in endometrial carcinoma.

  1997cited by this paper
• Genetic instability in colorectal cancers

  1997cited by this paper
• Mutational analysis of MLH1 and MSH2 in 25 prospectively‐acquired RER+ endometrial cancers

  1997cited by this paper
• Molecular evidence that most but not all carcinosarcomas of the uterus are combination tumors.

  1997cited by this paper
• Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies.

  1997cited by this paper
• Immunohistochemical analysis of the expression of cdk4 and p16INK4 in human endometrioid‐type endometrial carcinoma

  1997cited by this paper
• A dualistic model for endometrial carcinogenesis based on immunohistochemical and molecular genetic analyses.

  1997cited by this paper
• Identification of HER-2/neu oncogene amplification by fluorescence in situ hybridization in stage I endometrial carcinoma.

  1997cited by this paper
• p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesis.

  1997influential reference
• Microsatellite instability is uncommon in uterine serous carcinoma.

  1997cited by this paper
• Risk factors and hormone levels in patients with serous and endometrioid uterine carcinomas.

  1997cited by this paper
• Detection of DNA gains and losses in primary endometrial carcinomas by comparative genomic hybridization

  1997cited by this paper
• Clinical and pathological significance of microsatellite instability in sporadic endometrial carcinoma.

  1996cited by this paper
• Case-control study of endogenous steroid hormones and endometrial cancer.

  1996cited by this paper
• Endometrial carcinoma: the prognostic impact of papillary serous carcinoma (UPSC) in relation to nuclear grade, DNA ploidy and p53 expression.

  1996cited by this paper
• Comparison of benign and malignant endometrial lesions for their p53 state, using immunohistochemistry and temperature-gradient gel electrophoresis

  1996cited by this paper
• Lessons from Hereditary Review Colorectal Cancer

  1996cited by this paper
• Clear cell carcinoma of the endometrium: Prognosis and metastatic pattern

  1996cited by this paper
• Microsatellite instability: The mutator that mutates the other mutator

  1996cited by this paper
• K-ras point mutations in endometrial carcinoma: effect on outcome is dependent on age of patient.

  1996cited by this paper
• Mutation of MSH3 in endometrial cancer and evidence for its functional role in heteroduplex repair

  1996cited by this paper
• p53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumorigenesis.

  1995cited by this paper
• Mutations in DNA mismatch repair genes are not responsible for microsatellite instability in most sporadic endometrial carcinomas.

  1995cited by this paper
• Life‐time risk of different cancers in hereditary non‐polyposis colorectal cancer (hnpcc) syndrome

  1995cited by this paper
• Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation.

  1995cited by this paper
• Hereditary aspects of endometrial adenocarcinoma

  1995cited by this paper
• Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survival.

  1995cited by this paper
• Mutation and allelic loss of the p53 gene in endometrial carcinoma. Incidence and outcome in 92 surgical patients

  1995cited by this paper
• Mutations of the Ki-ras oncogene in carcinoma of the endometrium.

  1995cited by this paper
• Multivariable analysis of DNA ploidy, p53, and HER‐2/neu as prognostic factors in endometrial cancer

  1994cited by this paper
• Early mutational activation of the c-Ki-ras oncogene in endometrial carcinoma.

  1994cited by this paper
• Expression of EGFR, HER-2/neu, P53, and PCNA in endometrioid, serous papillary, and clear cell endometrial adenocarcinomas.

  1994cited by this paper
• The epidemiology of endometrial cancer in hereditary nonpolyposis colorectal cancer.

  1994cited by this paper

• Epidemiology, molecular typing, microbiome-immune interactions and treatment strategies of endometrial cancer: a review

  2025cites this paper
• EPM2 AIP1 immunohistochemistry as a surrogate of promoter methylation analysis in endometrial carcinoma

  2025cites this paper
• Molecular Pharmacological Interventions for Endometrial Cancer: A Comprehensive Review

  2025cites this paper
• Epidemiological trends in uterine corpus malignancies in Belarus: A 30-year analysis (1993-2022).

  2025cites this paper
• Level of DNA damage in peripheral blood mononuclear cells in endometrial cancer patients according to histological type and tumor differentiation

  2025cites this paper
• Calcifying nested stromal-epithelial tumor of the liver: Report of two cases revealing novel WT1 mutation and distinct epigenetic features.

  2025cites this paper
• Research trends and hotspots of single nucleotide polymorphisms in endometrial cancer: a bibliometric analysis

  2025cites this paper
• Immunohistochemical Evaluation of Phosphatase and Tensin Homolog (PTEN) Expression in Endometrial Lesions: A Cross-Sectional Study in a Tertiary Care Center in South India

  2025cites this paper
• The role of the Androgen Receptor (AR) in endometrial cancer aggressiveness: Correlation with other prognostic markers and therapeutic implications. A retrospective observational study.

  2025cites this paper
• Sarcopenia in gynaecological cancers.

  2024cites this paper
• The crucial value of serum ferritin in assessing high-risk factors and prognosis for patients with endometrial carcinoma

  2023cites this paper
• Endometrial hypoplasia in IVF programs in patients after treatment of atypical hyperplasia and early endometrial cancer

  2023cites this paper
• Histopathological and Immunohistochemical Prognostic Factors in High-Grade Non-Endometrioid Carcinomas of the Endometrium (HG-NECs): Is It Possible to Identify Subgroups at Increased Risk?

  2023cites this paper
• Examination of Factors Affecting Prognosis and Treatment Choice in Patients with Endometrial Cancer: A Retrospective Single-Center Experience

  2023cites this paper
• A review of basic to clinical targeted therapy and immunotherapy in uterine serous cancer

  2023cites this paper
• Endometrial Cancer. Guideline of the DGGG, DKG and DKH (S3-Level, AWMF Registry Number 032/034-OL, September 2022). Part 1 with Recommendations on the Epidemiology, Screening, Diagnosis and Hereditary Factors of Endometrial Cancer, Geriatric Assessment and Supply Structures

  2023cites this paper
• The Role of FBXW7 in Gynecologic Malignancies

  2023cites this paper
• Developing a novel DNA methylation risk score for survival and identification of prognostic gene mutations in endometrial cancer: a study based on TCGA data.

  2022cites this paper
• Extraterrestrial Gynecology: Could Spaceflight Increase the Risk of Developing Cancer in Female Astronauts? An Updated Review

  2022cites this paper
• Evaluation of Programmed Death Ligand-1 Immunohistochemical Expression and Tumor-Infiltrating Lymphocytes in Different Types of Endometrial Carcinoma

  2022cites this paper
• Türkiye

  2022cites this paper
• STUDY OF IMMUNOHISTOCHEMICAL EXPRESSION OF BETA-CATENIN IN ENDOMETRIAL BIOPSY SPECIMENS AMONG PATIENTS OF ABNORMAL UTERINE BLEEDING IN A TERTIARY CARE HOSPITAL

  2022cites this paper
• Natural Kinase Inhibitors for the Treatment and Management of Endometrial/Uterine Cancer: Preclinical to Clinical Studies

  2022cites this paper
• Prognostic value of the TCGA molecular classification in uterine carcinosarcoma

  2021cites this paper
• Transgenic mice overexpressing the LH receptor in the female reproductive system spontaneously develop endometrial tumour masses

  2021cites this paper
• New Pathological and Clinical Insights in Endometrial Cancer in View of the Updated ESGO/ESTRO/ESP Guidelines

  2021cites this paper
• Differential receptor tyrosine kinase phosphorylation in the uterus of rats following developmental exposure to tetrabromobisphenol A

  2021cites this paper
• Postoperative Radiotherapy for Endometrial Cancer in Elderly (≥80 Years) Patients: Oncologic Outcomes, Toxicity, and Validation of Prognostic Scores

  2021cites this paper
• Comprehensive approach to diagnostic cytology in endometrial pathology (review of literature).

  2021cites this paper
• A Narrative Review of the Role of Diet and Lifestyle Factors in the Development and Prevention of Endometrial Cancer

  2021influential citation
• Integrative Analysis of Differently Expressed Genes Reveals a 17-Gene Prognosis Signature for Endometrial Carcinoma

  2021cites this paper
• HISTOPATHOLOGICAL AND IMMUNOHISTOCHEMICAL PROGNOSTIC FACTORS IN HIGH-GRADE NON-ENDOMETRIOID CARCINOMAS OF THE ENDOMETRIUM (HG-NECs). IS IT POSSIBLE TO IDENTIFY SUB-GROUPS AT INCREASED RISK?

  2021cites this paper
• PTEN protein expression has role in predicting disease-free-interval in endometrioid endometrial carcinoma

  2021cites this paper
• Clear cell endometrial carcinomas with mismatch repair deficiency have a favorable prognosis: A systematic review and meta-analysis.

  2021cites this paper
• A Clinical Prognostic Decision Support System for the Prediction of the Prognosis of Patients with Endometrial Cancer Name :

  2020cites this paper
• Nuclear Beta-Catenin Expression in Endometrioid Intraepithelial Neoplasia (Atypical Hyperplasia) Does Not Predict Carcinoma on Subsequent Hysterectomy.

  2020cites this paper
• Histone deacetylase 3 (HDAC3) inhibitors as anticancer agents: A review.

  2020cites this paper
• Examination of expression patterns of WNT signaling in the human fallopian tubes

  2020cites this paper
• The tumor suppressor protein PTEN undergoes amyloid-like aggregation in tumor cells

  2020cites this paper
• Increased osteopontin expression in endometrial carcinoma is associated with better survival outcome.

  2020cites this paper
• Proteomics Based Mongolian Medicine Modified Sugmul-7 Mechanism of Regulating Endocrine Function in Hyperplasia of the Breast

  2020cites this paper
• Immune Checkpoint Inhibitors: A Promising Choice for Endometrial Cancer Patients?

  2020cites this paper
• Endometrial Cancer, the Current International Federation of Gynecology and Obstetrics Staging System, and the Role of Imaging

  2020cites this paper
• Concurrent Endometrial Carcinoma in Endometrial Hyperplasia with Atypia

  2020cites this paper
• A Diagnostic Approach to Endometrial Cytology by Means of Liquid-Based Preparations

  2019cites this paper
• Histone deacetylase 8 (HDAC8) and its inhibitors with selectivity to other isoforms: An overview.

  2019cites this paper
• The androgen receptor antagonist enzalutamide induces apoptosis, dysregulates the heat shock protein system, and diminishes the androgen receptor and estrogen receptor β1 expression in prostate cancer cells

  2019cites this paper
• Anti-estrogen Treatment in Endometrial Cancer: A Systematic Review

  2019cites this paper
• Culture characters, genetic background, estrogen/progesterone receptor expression, and tumorigenic activities of frequently used sixteen endometrial cancer cell lines.

  2019cites this paper
• Molecular Diagnosis of Uterine Cancer

  2019cites this paper
• Comparison of clinicopathologic and survival characteristics of high grade endometrial cancers; single center experience.

  2019cites this paper
• GREB1‐CTNNB1 fusion transcript detected by RNA‐sequencing in a uterine tumor resembling ovarian sex cord tumor (UTROSCT): A novel CTNNB1 rearrangement

  2019cites this paper
• Expression of p53 and PTEN in human primary endometrial carcinomas: Clinicopathological and immunohistochemical analysis and study of their concomitant expression

  2019cites this paper
• Kobe University Repository : Kernel タイトル Tit le Correlat ive Expression of Cyclooxygenase-1 ( Cox-1 ) and Human Epidermal Growth Factor Receptor Type-2 ( Her-2 ) in Endometrial Cancer 著者

  2019influential citation
• Study of the Association of Phosphatase and Tensin Homolog and p27 Expressions in Endometrial Hyperplasia and Carcinoma

  2019cites this paper
• Ovary and Peritoneal Washings

  2019cites this paper
• Endometrial Cancer: From Biological to Clinical Approaches

  2019cites this paper
• Prognostic classification of endometrial cancer using a molecular approach based on a twelve-gene NGS panel

  2019cites this paper
• Unsupervised Clustering of Immunohistochemical Markers to Define High-Risk Endometrial Cancer

  2019cites this paper
• ROR1 and ROR2 play distinct and opposing roles in endometrial cancer.

  2018cites this paper
• Miniseries of reviews: gynecological pathology

  2018cites this paper
• Increased protein arginine methyl transferase 7 expression is correlated with the occurrence and development of endometrial carcinoma

  2018cites this paper
• Therapy Implications of DNA Mismatch Repair Deficiency, Microsatellite Instability, and Tumor Mutation Burden

  2018cites this paper
• Endometriyal Patolojilerde Prostat Spesifik Antijen Ekspresyonunun İncelenmesi

  2018cites this paper
• Gynecologic Cancers: Molecular Updates 2018.

  2018cites this paper
• Effects of KRAS Gene Mutations in Gynaecological Malignancies

  2018cites this paper
• Caracterización molecular de los carcinosarcomas de endometrio.

  2018cites this paper
• Expression of p53, Bcl-2 and Bax in endometrial carcinoma, endometrial hyperplasia and normal endometrium: a histopathological study

  2018cites this paper
• Genome-Wide Analyses Identify Filamin-A As a Novel Downstream Target for Insulin and IGF1 Action

  2018cites this paper
• Hydroxysteroid (17beta) dehydrogenase 1 expression enhances estrogen action and serves as a potential drug target for reducing estrogen signaling in the uterus and mammary glands

  2018cites this paper
• Caracterización transcriptómica del cáncer de endometrio y su importancia en el diseño de nuevas estrategias terapéuticas

  2018cites this paper
• Second Opinion Expert Pathology in Endometrial Cancer: Potential Clinical Implications

  2017cites this paper
• Checkpoint inhibitors in endometrial cancer: preclinical rationale and clinical activity

  2017cites this paper
• Interobserver Agreement in Endometrial Carcinoma Histotype Diagnosis Varies Depending on The Cancer Genome Atlas (TCGA)-based Molecular Subgroup

  2017cites this paper
• Genetic and Epigenetic Dysregulation in Endometrial Carcinoma

  2017cites this paper
• Aplicabilidad de la RT-PCR a tiempo real a partir de tejido fijado en formol e incluido en parafina a la búsqueda de perfiles de expresión génica con valor pronóstico en cáncer de endometrio

  2017cites this paper
• Prognostic markers and the individualized management of endometrial carcinomas

  2017cites this paper
• Histone modifications: A review about the presence of this epigenetic phenomenon in carcinogenesis.

  2017cites this paper
• Over Expression of Apoptotic p53 and Epidermal Growth Factor Receptor in endometrial Cancer and Benign

  2017cites this paper
• Genomics in Gynecological Cancer: Future Perspective

  2017cites this paper
• Molecular Pathology of Uterine Carcinosarcoma

  2017cites this paper
• Pathology of Endometrial Carcinoma.

  2017cites this paper
• Exon 3 mutations of CTNNB1 drive tumorigenesis: a review

  2017cites this paper
• Biomarkers of Endometrial Cancer

  2017cites this paper
• Epidemiologic and Clinical Profiles of Uterine Cancer in the Gharbiah Province of Egypt

  2017cites this paper
• Classification of Endometrial Carcinoma

  2017cites this paper
• Elevated Serum Levels of Estradiol Induce Endometrial Hyperplasia Rather than Carcinoma in a Mouse Model Using a Carcinogen

  2017cites this paper
• L1CAM expression in endometrial carcinomas: an ENITEC collaboration study

  2016cites this paper
• Serous versus high-grade endometrioid endometrial carcinoma: immunohistochemistry of RFP is not useful for differentiation.

  2016cites this paper
• Disruption of estrogen homeostasis as a mechanism for uterine toxicity in Wistar Han rats treated with tetrabromobisphenol A.

  2016cites this paper
• [New features in the 2014 WHO classification of uterine neoplasms].

  2016cites this paper
• TOWARDS PRECISION MEDICINE IN ENDONETRIAL CANCER

  2016cites this paper
• An update of the classical Bokhman's dualistic model of endometrial cancer

  2016cites this paper
• Immunohistochemical Profiling of Endometrial Serous Carcinoma

  2016cites this paper
• Neues in der WHO-Klassifikation 2014 der Tumoren des Corpus uteri

  2016cites this paper
• The emerging role of long non-coding RNAs in endometrial cancer.

  2016cites this paper
• Defective DNA Mismatch Repair Influences Expression of Endometrial Carcinoma Biomarkers

  2016cites this paper
• Therapeutic Modalities in Early-Stage Uterine Papillary Serous Carcinomas, Carcinosarcomas, Clear-Cell and Mixed Histology Carcinomas: Treatment of Choice Is Combined Chemotherapy and Radiation

  2016influential citation
• Median Survival Time of Endometrial Cancer Patients with Lymphovascular Invasion at the Hospital Universiti Sains Malaysia.

  2016cites this paper
• Immunohistochemical Profiles of Endometrioid Endometrial Carcinomas With and Without Metastatic Disease

  2016cites this paper